Araceli Biosciences raises $11.2M in Seed financing to accelerate drug discovery innovations, led by several investors.
Amount Raised
$11.2 Million
Round Type
Seed
PortlandBiotechnologyHealthcareDescription
Araceli Biosciences has successfully completed its Seed funding round, raising $7.2 million in new equity investment and converting $4.0 million in SAFEs. This funding will propel Araceli's commercial expansion and scale manufacturing. The company's focus is on advancing its AI-driven product offerings in high-content imaging. Since Araceli's spinout from Phoseon Technology, total financing has reached $11.2M.
Who to call at Araceli Biosciences, and when
A new round usually means Araceli Biosciences is about to hire and buy. The teams that reach out first get the meeting.
- An alert the day Araceli Biosciences raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Araceli Biosciences, from your own LinkedIn network
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Araceli Biosciences raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Araceli Biosciences raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.